Science

AddToAny

Google+ Facebook Twitter Twitter

Working conditions in transfusion laboratories a snapshot

Nikki Swarbrick, Laboratory Incident Specialist at SHOT, talks through the key findings from a survey of UK transfusion laboratories.

The United Kingdom Transfusion Laboratory Collaborative (UKTLC) carried out a biennial survey, which is sent to all UK transfusion laboratories that report to the Serious Hazards of Transfusion (SHOT) haemovigilance scheme.

It is intended to represent a “snapshot” of working conditions within the laboratory on a single day. Key findings from previous surveys, which were undertaken in 2013–2019, highlighted concerns with workloads, staffing levels, increased vacancies, training of inexperienced staff and inadequate specialist support.

Key findings of the latest survey include:

Staffing: Increased workload, increased vacancies and difficulties in recruitment and retention.

Qualifications, knowledge and skills: Increased difficulties in training and maintaining competency and reduced satisfaction with newly qualified Health and Care Professions Council (HCPC)-registered biomedical scientists.

Information technology (IT): Limited number with full vein–to–vein IT.

Just culture: Improved ability to raise concerns, increased learning from excellence, increasing incorporation of human factors in practice.

Click here to read the full article

Image credit | Science-Photolibrary

 

 

Related Articles

Transfusion: training hub

Jill Caulfield, Transfusion 2024 Education Development Lead at NHS Blood and Transplant, introduces a “one-stop shop” of training resources.

VR-headset - CREDIT -getty

Improving transfusion with training

Ruth Evans and Laura Eastwood from NHS Blood and Transplant discuss virtual reality training for blood transfusion testing.

red blood cells CREDIT-iStock-1227353965

Casestudy acquired protein s deficiency

Healthcare Science Section Lead in Haematology and Haemostasis Michelle Bolam presents a case study in which a two-year-old presented with an unprovoked extensive deep vein thrombosis.

paper cuts - CREDIT - Richard-Gleed

DNA: Cutting the future of genome editing

The latest CRISPR-Cas technology has been used to eliminate all traces of HIV from infected cells in the lab. Here we look at how gene editing could revolutionise clinical treatments and ask what the limitations are for its future use.

Top